Resources
Clinical Trials Information System (CTIS) Webinar
📣Attention all clinical trial sponsors who are planning to conduct a study in the EU or EEA! Beginning on January 31, 2023, the Clinical Trials Information System (CTIS) must be used to submit any new clinical trial application in these regions. This new process permits a single application to secure authorizations in up to 30 […]
Palmoplantar Pustulosis (PPP) Case Study
Click here for a PDF version of this case study Outcomes Innovaderm successfully managed this PPP study and this resulted in: Enrollment completed 3 weeks ahead of schedule; Successful study and satisfied sponsor Study Characteristics Study Phase: II Patient Population: Palmoplantar pustulosis IP Route of Administration: Systemic Sites Distribution: 17 sites in 2 countries […]
Tips For a Successful Study in Medical Aesthetics Webinar
Watch this exciting and informative webinar about best practices on medical aesthetic studies from our industry experts. You will learn about: Insight into industry trends and key study design considerations; How to execute studies quickly without compromising data quality; Benefits and limits of qualitative image-derived evaluations From our industry Experts: Jasmina Jankicevic, Chief Medical Officer, […]
Notalgia Paresthetica (NP) Case Study
Click here for a PDF version of this case study Study Characteristics Study Phase: II Patient Population: 126 patients with Notalgia Paresthetica (NP) (Pruritus associated with NP) IP Route of Administration: Systemic (oral) Site Distribution: 33 sites (USA and Canada) Study Procedures: Photographs, Pharmacokinetics, Electrocardiograms Study Challenges Patient awareness: Challenge in advertisement as […]
Non-invasive methods to study molecular biomarkers in the skin: Tape Stripping and Beyond
Please join us for this unique webinar to learn more about non-invasive methods to collect and evaluate skin biomarkers in clinical trials. You will learn more about: Tape stripping techniques Sensitivity of various cutaneous biomarkers Non-invasive sample collection methods for skin protein and RNA analysis Questions? Contact us
Alopecia Areata Case Study
Click here for a PDF version of this case study Outcomes Innovaderm’s outstanding support on this alopecia areata study resulted in a rapid increase in enrollment rates and the successful management of this trial Study Characteristics Study Phase: II Patient Population: Alopecia Areata IP Route of Administration: Systemic Sites distribution: 12 sites (CAD-USA) Complex […]
Atopic Dermatitis (AD) Case Study
Click here for a PDF version of this case study Outcomes Innovaderm successfully managed this AD study and this resulted in: Enrollment completed 2 months earlier than planned; Innovaderm CRU recruited 33% of patients Study Characteristics Study Phase: Ib Patient Population: 36 subjects with moderate to severe AD IP Route of Administration: Systemic - […]
Acne Case Study
Click here for a PDF version of this case study Outcomes Innovaderm successfully managed this acne study and this resulted in: Enrollment completed 1 month earlier than planned Study Characteristics Study Phase: II Patient Population: Acne vulgaris (enrolling pediatrics & adults) IP Route of Administration: Systemic Sites distribution: 15 sites (USA) Study […]
Palmoplantar Pustulosis (PPP) Rescue Case Study
Click here for a PDF version of this case study Outcomes Innovaderm successfully transitioned this rescue study from another CRO and this resulted in: Increase in enrollment of over 10x Tripled site performance post transition On-time patient recruitment Study Characteristics Study Phase: II Study Status: Rescue study Patient Population: Palmoplantar pustulosis (PPP) IP Route […]
Skin Barrier Dysfunction: Atopic Dermatitis and Beyond
Don't miss this opportunity to join us for an informative session on skin barrier dysfunction where you will learn about: The disorder and its role in atopic dermatitis The impact of immune dysregulations and microbiome abnormalities on inherent skin barrier anomalies Methods to study skin barrier integrity in clinical trials Questions? Contact us
How to Write First-Rate Protocols for an Atopic Dermatitis Study - Focus: CLINICAL ASSESSMENTS AND ENDPOINTS
In recent years, therapeutics for dermatologic conditions have become a subspecialty of growing interest in the Clinical Research Organisation (CRO) industry, with clinical research in the area focused on a wide range of skin indications, such as acne vulgaris, psoriasis, and atopic dermatitis. What is atopic dermatitis? Atopic dermatitis (AD), also known as atopic eczema, […]
How to Write First-Rate Protocols for an Atopic Dermatitis Study - Focus: TREATMENT DURATION AND KEY ELIGIBILITY CRITERIA
In recent years, therapeutics for dermatologic conditions have become a subspecialty of growing interest in the Clinical Research Organisation (CRO) industry, with clinical research in the area focused on a wide range of skin indications, such as acne vulgaris, psoriasis, and atopic dermatitis. What is atopic dermatitis? Atopic dermatitis (AD), also known as atopic eczema, […]
How to Write First-Rate Protocols for an Atopic Dermatitis Study - Focus: STUDY DESIGN
In recent years, therapeutics for dermatologic conditions have become a subspecialty of growing interest in the Contract Research Organisation (CRO) industry, with clinical research in the area focused on a wide range of skin indications, such as acne vulgaris, psoriasis, and atopic dermatitis. What is atopic dermatitis? Atopic dermatitis (AD), also known as atopic eczema, […]
The Art of Protocol Writing in Dermatology
Watch this exciting and informative webinar on how to write the best protocols in dermatology. You will learn about: protocol development and associated tools; protocol considerations for key dermatology indications; clinical assessments, eligibility criteria, study design and more! Questions? Contact us
How to Handle Missing Data in Dermatology Trials Webinar
Watch this unique webinar to learn more about how to handle missing data in dermatology trials. You will learn more about: How missing data arises in dermatology studies Which statistical methods to choose to deal with missing data Which methods may be preferred by the Regulatory Bodies Questions? Contact us
